Supplemental Figure 2

1
0 0.05 0.1 0.15 0.2 0.25 0.3 0.35 0.4 0.45 0.5 0 0.025 0.0625 0.0825 0.1125 0.1375 0.175 0.2 0.225 0.2625 0.2825 0.3125 0.3375 0.375 0.4 0.425 0.4625 0.4825 0.5 0.7 0.9 dS Frequency Supplemental Figure 2

description

Supplemental Figure 2. - PowerPoint PPT Presentation

Transcript of Supplemental Figure 2

Page 1: Supplemental Figure 2

0

0.05

0.1

0.15

0.2

0.25

0.3

0.35

0.4

0.45

0.5

0

0.025

0.0625

0.0825

0.1125

0.1375

0.175

0.2

0.225

0.2625

0.2825

0.3125

0.3375

0.375

0.4

0.425

0.4625

0.4825 0.5

0.7

0.9

dS

Frequency

Supplemental Figure 2

1. Supplemental Figure 1 - International Journal of ... · Supplemental Figure 1 2. Supplemental Figure 2 3. Supplemental Figure 3 4. Supplemental Figure 4 5. Supplemental Figure

1. Supplemental Figure 1 - International Journal of ... · Supplemental Figure 1 2. Supplemental Figure 2 3. Supplemental Figure 3 4. Supplemental Figure 4 5. Supplemental Figure

Supplemental Figure 1 - Journal of CancerSupplemental Figure 2 . Supplemental Figure 3 . Supplemental Table 1. Relationship between CD4 TIL expression and various patient characteristics

Supplemental Figure 1 - Journal of CancerSupplemental Figure 2 . Supplemental Figure 3 . Supplemental Table 1. Relationship between CD4 TIL expression and various patient characteristics

Supplemental Figure 2. Psychophysiological interaction ...

Supplemental Figure 2. Psychophysiological interaction ...

Supplemental Figure 1

Supplemental Figure 1

Supplemental materials 2 Supplemental Figure 1.Antibody ...dm5migu4zj3pb.cloudfront.net/manuscripts/66000/66824/JCI66824sd.pdf · Supplemental Figure . PRL5 -3 is expressed at higher

Supplemental materials 2 Supplemental Figure 1.Antibody ...dm5migu4zj3pb.cloudfront.net/manuscripts/66000/66824/JCI66824sd.pdf · Supplemental Figure . PRL5 -3 is expressed at higher

Supplement Supplemental Figures and Supplemental Figure ...

Supplement Supplemental Figures and Supplemental Figure ...

Supplemental Figure 2 - Cancer Discovery · SUPPLEMENTAL FIGURE 2. Title: Supplemental Figure 2 Created Date: 7/29/2016 10:43:37 AM ...

Supplemental Figure 2 - Cancer Discovery · SUPPLEMENTAL FIGURE 2. Title: Supplemental Figure 2 Created Date: 7/29/2016 10:43:37 AM ...

Supplemental Digital Content Supplemental Figure 1 ...

Supplemental Digital Content Supplemental Figure 1 ...

Supplemental Figure 1. Supplemental Figure 2 Supplemental Figure 3 A B.

Supplemental Figure 1. Supplemental Figure 2 Supplemental Figure 3 A B.

Supplemental Figures S1-S8. Supplemental Figure S1.

Supplemental Figures S1-S8. Supplemental Figure S1.

Supplemental figure 2

Supplemental figure 2

SUPPLEMENTAL INFORMATION 1. Supplemental …misclab.umeoce.maine.edu/documents/BehrenfeldBoss2014...Supplemental Figure 2. Identifying bloom initiation during exponential growth. Using

SUPPLEMENTAL INFORMATION 1. Supplemental …misclab.umeoce.maine.edu/documents/BehrenfeldBoss2014...Supplemental Figure 2. Identifying bloom initiation during exponential growth. Using

Supplemental figure 2.

Supplemental figure 2.

Supplemental Figures Supplemental Figure 1€¦ · Supplemental Figures . Supplemental Figure 1 . Supplemental Figure 1. AdipoChaser mouse models used for cold and thermoneutral exposures.

Supplemental Figures Supplemental Figure 1€¦ · Supplemental Figures . Supplemental Figure 1 . Supplemental Figure 1. AdipoChaser mouse models used for cold and thermoneutral exposures.

Supplemental Figure 1 A B panobinostat. OCI-AML3 Supplemental Figure 2 Control2050 nM BC2059, 24 hr A B.

Supplemental Figure 1 A B panobinostat. OCI-AML3 Supplemental Figure 2 Control2050 nM BC2059, 24 hr A B.

Supplemental Figure S1

Supplemental Figure S1

Supplemental Figure 1, related to Figure 1genesdev.cshlp.org/.../Supplemental_Figures.pdf · Supplemental Figure 2, related to Figure 2 (A-B) Full sequences of mouse Dll4in3 enhancer

Supplemental Figure 1, related to Figure 1genesdev.cshlp.org/.../Supplemental_Figures.pdf · Supplemental Figure 2, related to Figure 2 (A-B) Full sequences of mouse Dll4in3 enhancer

Supplemental Information Recruitment of UBPY and ESCRT ...Supplemental Movie 2, related to Figure 1(available online) Supplemental Movie 3, related to Figure 1(available online) Supplemental

Supplemental Information Recruitment of UBPY and ESCRT ...Supplemental Movie 2, related to Figure 1(available online) Supplemental Movie 3, related to Figure 1(available online) Supplemental

Supplemental digital content€¦ · Web viewSupplemental Figure 1. Figure that demonstrates co-cited authors that analyzed by CiteSpace. Supplemental Figure 2. Figure that demonstrates

Supplemental digital content€¦ · Web viewSupplemental Figure 1. Figure that demonstrates co-cited authors that analyzed by CiteSpace. Supplemental Figure 2. Figure that demonstrates

Figure Legends for Supplemental Figures Supplemental

Figure Legends for Supplemental Figures Supplemental